Impact of multidrug-resistant Pseudomonas aeruginosa bloodstream infections on mortality in oncology patients
The Journal of Infection in Developing Countries · 30.04.2026 · 20 (04) · 566-573
DOI: 10.3855/jidc.22272 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Infection in Developing Countries, online erschienen am 30.04.2026. Verfasst von Israel Gallardo-Pineda und 7 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico. Hauptthemen laut MEDLINE: Pseudomonas Infections, Pseudomonas aeruginosa, Drug Resistance, Multiple, Bacterial, Bacteremia. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Pseudomonas aeruginosa (PAE) is among the most frequent causes of bloodstream infections (BSIs) in cancer patients. Resistant strains are associated with increased morbidity and mortality. Methodology: A retrospective study was conducted at a tertiary oncology hospital in Mexico City, including all episodes of PAE-BSI. The isolates were classified as susceptible, carbapenem-resistant (CR), multidrug-resistant (MDR), or difficult-to-treat resistant (DTR).
Results
A total of 259 PAE-BSI episodes were analyzed: 202 (78.4%) susceptible, 19 (7.3%) CR, 13 (5.0%) MDR, and 25 (9.7%) DTR. Resistant strains were significantly associated with prior antibiotic use (84.2% vs. 52.5%), more extended hospital stays (18 vs. 9 days), septic shock (36.8% vs. 19.8%), and inappropriate empiric therapy (54.4% vs. 19.3%). Overall, 30-day mortality was 38.2%, rising to 47.4% in CR, 84.6% in MDR, and 76% in DTR cases; compared with 29.7% in susceptible isolates (p < 0.001). No mortality benefit was observed with combination therapy compared to monotherapy. Multivariate analysis indicated that age ≥ 60 years, advanced oncological status, secondary bacteremia, septic shock, invasive mechanical ventilation, inadequate source control, and carbapenem strains were independent predictors of 30-day mortality. Appropriate antimicrobial therapy was a protective factor.
Conclusions
Resistant PAE-BSI in cancer patients was associated with longer hospitalizations and a significantly increased mortality rate. Appropriate antimicrobial therapy can lead to a reduction in mortality.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Infectious Diseases Department, Instituto Nacional de Cancerología (INCan), Mexico City, Mexico.
- Laboratory of Microbiology (INCan), Cancerología (INCan), Mexico.
Zitieren
APA
Gallardo-Pineda, I., Volkow-Fernández, P., Velázquez-Acosta, C., Camiro-Zúñiga, A., Barajas-Silva, A., Mendoza-Ramírez, M. J., Magallanes-López, A., & Cornejo-Juárez, P. (2026). Impact of multidrug-resistant Pseudomonas aeruginosa bloodstream infections on mortality in oncology patients. The Journal of Infection in Developing Countries, 20(04), 566-573. https://doi.org/10.3855/jidc.22272
Vancouver
Gallardo-Pineda I, Volkow-Fernández P, Velázquez-Acosta C, Camiro-Zúñiga A, Barajas-Silva A, Mendoza-Ramírez MJ, et al. Impact of multidrug-resistant Pseudomonas aeruginosa bloodstream infections on mortality in oncology patients. The Journal of Infection in Developing Countries. 2026;20(04):566-573. doi:10.3855/jidc.22272
BibTeX
@article{GallardoPineda2026,
author = {Gallardo-Pineda, Israel and Volkow-Fernández, Patricia and Velázquez-Acosta, Consuelo and Camiro-Zúñiga, Antonio and Barajas-Silva, Ariadna and Mendoza-Ramírez, María-José and Magallanes-López, Alberto and Cornejo-Juárez, Patricia},
title = {Impact of multidrug-resistant Pseudomonas aeruginosa bloodstream infections on mortality in oncology patients},
journal = {The Journal of Infection in Developing Countries},
year = {2026},
volume = {20},
number = {04},
pages = {566--573},
doi = {10.3855/jidc.22272}
}
EUVIMED